© 2004 by the American Diabetes Association, Inc.
Orlistat Augments Postprandial Increases In Glucagon-Like Peptide-1 in Obese Type 2 Diabetic PatientsResponse to Horowitz et al.
1 Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, Istanbul University Cerrahpasa Medical School, Istanbul, Turkey Address correspondence to Taner Damci, MD, Atakoy 4, Kisim O-67 D:7, 34750 Atakoy, Istanbul, Turkey. E-mail: tdamci@superonline.com
We thank Horowitz et al. (1) for their comments on our article (2) on the effect of orlistat on postprandial glucose, insulin, and incretin levels. They raise criticisms regarding the increase in postprandial GLP-1 levels, asserting
|
| |||||||||||||||||||||||||||